Dr. Sarah Cork

Sarah leverages her Ph.D. in Neuroscience and professional training in translational biologic drug discovery to bring scientific depth to her legal practice. Her technical expertise spans a broad array of cutting-edge technologies including immunotherapies, antibody-drug conjugates, AI-enabled precision medicine, cell-free diagnostic techniques, oligonucleotides for spatial transcriptomics and gene silencing, IVF and ocular surgical techniques, medical devices including pen injectors and aortic stents, gene sequencing, recombinant DNA technology, consumables, and biologic and small molecule therapies targeting diabetes, cancer, HIV, and dermatological, urological, and neurological conditions.

Sarah works closely with her clients to protect their innovations and develop IP strategies that support both immediate and long-term business objectives.

Her practice encompasses patent prosecution, IP due diligence, freedom-to-operate analyses, and strategic counseling on patent scope, validity, and enforceability. She also advises on due diligence in licensing and M&A transactions in the life sciences sector.

As a litigator and PTAB practitioner, Sarah is deeply familiar with all phases of a matter, from pre-suit investigation, discovery, and dispositive motion practice through trial and appeal. Her teams rely on her unique ability to craft sophisticated merits arguments and manage technical subject matter experts efficiently.